Obesity-associated alterations in adipokine concentrations, namely leptin and adiponectin, underpin the development of adipose tissue dysfunction, thus supporting an environment conducive to cardiometabolic disease [1, 2]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.